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retrospectivelygatheredandprospectively analyzed forprocedural success
(reduction in LVOT gradient) and procedural complications.
RESULTS There were 298 males (5313y) and 347 females (6015.5y).
The male cohort received a higher dose of alcohol; however, there
were no other differences in procedural success, mortality, or need for
permanent pacemaker implantation. (Table 1) There were 555
Caucasian (5715y) and 59 African American (5915y) patients in the
study. African American patients had more septal arteries injected
with more alcohol, a higher post ablation creatinine kinase level,
and a greater reduction in peak LVOT gradient compared to the
Caucasian cohort. There was no difference in procedural mortality
or the need for permanent pacemaker. (Table 2)Male (STD; CI; or
number of
incident)Female (STD; CI;
or number of
incident)P value for
genderCaucasian (STD;
CI; or number of
incident)African American
(STD; CI; or
number of
incident) P value for raceN 298 347 NA 555 59 NAAge 53 (14; þ/- 1.5) 60 (15.5; þ/- 1.6) 0.0000000056 57 (15; þ/- 1.25) 59 (14; þ/- 4) 0.3Reduction in
Gradient87 (51; þ/- 6.14) 84 (54.8; þ/- 6.1) 0.85 84 (50; þ/- 4.5) 99 (55; þ/- 16) 0.05Number of
Septal
Arteries
Injected1.16 (0.4; þ/-
0.05)1.16 (0.45; þ/-
0.05)0.96 1.15 (0.4; þ/-
0.03)1.26 (0.5; þ/-
0.13)0.05Amount of
EtHO
Injected2.27 (0.7; þ/-
0.08)2.14 (0.76; þ/-
0.08)0.03 2.2 (0.74; þ/-
0.06)2.34 (0.7; þ/-
0.2)0.09Peak Creatinine
Kinase1194 (701; þ/- 81) 1082 (790; þ/-
85)0.06 1099 (765; þ/-
65)1426 (646; þ/-
170)0.001Rate of Heart
Block
Requiring
PPM6 % (18 of 298) 6.9% (24 of 347) 0.65 6.3 % (35 of 555) 8.5% (5 of 59) 0.52Procedural
Death1% (2 of 298) 1.2 % (4 of 347) 0.52 0.9% (5 of 555) 1.7 % (1 of 59) 0.55CONCLUSIONS There was no signiﬁcant effect of gender on the out-
comes of alcohol septal ablation. Despite the need for more septals
injected and ahigher alcohol dose (larger infarct size) inAfricanAmerican
patients, the clinical outcomes were similar to the Caucasian cohort. The
higher alcohol dose and infarct size likely reﬂects the greater septal hy-
pertrophy typically seen in African American patients with HOCM.
CATEGORIES STRUCTURAL: Alcohol Septal Ablation/HOCM
KEYWORDS Ablation, alcohol septal, Hypertrophic obstructive car-
diomyopathy, Racial disparities
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Endovascular Therapy Versus Medical Therapy for Management of Acute
Ischemic Stroke: Systematic Review and Meta-Analysis of Prospective
Randomized Controlled Trials
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Gaurav Rao,1 Oluﬁsayo Otusanya,3 Jose D. Tafur,4 Mohsin Salih,5
Divyanshu Mohananey,6 Mohammed Makkiya,1 Christopher White7
1Monteﬁore Medical Center/Albert Einstein College of Medicine, New
York, NY; 2The John H. Stroger, Jr. Hospital, Chicago, IL; 3Jacobi
Medical Center, New York, NY; 4Ochsner Medical Center, New Orleans,
LA; 5St Lukes hospital, Bollwin, MO; 6John H Stroger Hospital of Cook
County, Chicago, IL; 7University of Queensland, Queensland, Australia,
New Orleans, USABACKGROUND Several randomized controlled trials (RCTs) have
shown inconsistent results in regards to outcomes in patients with
acute ischemic stroke (AIS) undergoing endovascular therapy (ET)
versus standard medical treatment (MT). Thus we sought to evaluate
the effectiveness and safety of ET compared to MT in patients with
AIS utilizing data from all available RCTs.
METHODS We conducted electronic searches of RCT. The primary
efﬁcacy endpoints were modiﬁed Rankin scale 0 to 2, recurrent stroke,
and all-cause mortality. Safety endpoints included intracranial hem-
orrhage (ICH) and all-bleeding events. Odds ratios (OR) and 95%
conﬁdence intervals (CI) computed using the Mantel-Haenszel
method. Random-effect model was used. Sensitivity analysis and bias
quantiﬁcation were also assessed.
RESULTS Ten RCTs were included, with a total of 2,716 patients. There
was a signiﬁcant difference favoring ET compared to MT for modiﬁed
Rankin scale score 0 to 2 (OR: 0.62; 95% CI: 0.44 to 0.86; p< 0.01). We
found no difference between ET vs. MT for all-cause mortality (OR:
0.92; 95% CI: 0.74 to 1.14; p¼ 0.42) and recurrent stroke (OR: 1.82; 95%
CI: 0.79 to 4.16; p¼ 0.16). For safety outcomes, there was an increased
risk of all-bleeding events (OR: 1.91; 95% CI: 1.22 to 3.00; p< 0.01) and
ICH (OR: 1.95; 95% CI: 1.24 to 3.06; p< 0.01) following ET. Sensitivity
analysis of one study removal showed that exclusion of the PROACT II
study from the analysis for all-bleeding and ICH outcomes changed the
ﬁnal effect to a non-signiﬁcant difference between both approaches.
No evidence of publication bias was observed. The number needed to
treat for a Rankin score 0 to 2 is 8; the number needed to harm for all-
bleeding and ICH is 8 and 10 respectively.
CONCLUSIONS The results of this meta-analysis indicate that in pa-
tients with AIS, ET is superior to standard MT for disability-free sur-
vival, with an increased risk of bleeding and ICH.
CATEGORIES ENDOVASCULAR: Stroke and Stroke Prevention
KEYWORDS Endovascular therapy, Meta-analysis, Stroke, acute is-
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BACKGROUND We retrospectively analyzed data from our center to
quantify complication rates in patients undergoing carotid artery stent-
ing (CAS). Thereby, we sought to evaluate a possible association between
the vessel (left vs. right) treated and the respective complication rate.
METHODS In a retrospective analysis of 1124 consecutive patients
(pts) undergoing CAS at our institution between December 1997 and
January 2015, 557 pts (49,6%) underwent stenting of the left carotid
artery (group 1) and 567 pts (50,4%) of the right carotid artery (group
2). Thirteen patients with a simultaneous intervention of both carotid
arteries were excluded from our analysis. The baseline data of both
groups were similar (mean age 71.4  38.9 years, 175 females (31.4%)
in group 1 versus mean age of 71.9  39.1 years and 189 females (33.3%)
in group 2; no differences in comorbidities).
RESULTS CAS was successful in all but 32 patients (13 [2.3%] of them in
group 1, and 19 [3.6%] in group 2, p¼ns). The mean degree of stenosis
was reduced from 85.5 10.3% to 3.1 6.4% in group 1, and 85.9 9.6%
to 3.5 7.3% in group 2, respectively (p¼ns). Themean stent lengthwas
27.9  6.7 mm in group 1 and 27.5  9.8 mm in group 2 (p¼ns), and the
mean procedure timewas not different between both groups (17.2 11.4
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complications (fatal or non-fatalmajor stroke,minor stroke, PRIND, TIA
or death) was 10.1% in group 1 and 6.7% in group 2 (p¼0.042). After the
introduction of cerebral protection devices in April 2004, a signiﬁcant
reduction of the complication could be observed in all patients (11.1%
without and 6.5% with protection). With respect to the two groups
deﬁned above, reduction was signiﬁcant in group 1 (14.8% without and
7.1% with protection device [p¼0.003]) whereas in group 2 only a pos-
itive trend from 7.8% to 6,0% (p¼0.402) could be found.
CONCLUSIONS There are different peri-interventional complication
rates in pts undergoing CAS depending on the vessel treated. The
more complex anatomical situation at the origin of the left carotid
artery might result in a more frequent mobilization of intraluminal
plaque components from the aorta or the truncus brachiocephalicus.
The signiﬁcant reduction of cerebrovascular events when using ﬁlter
devices corroborates this hypothesis.
CATEGORIES ENDOVASCULAR: Stroke and Stroke Prevention
KEYWORDS Carotidartery stenting, Carotid intervention, Carotid stenosis
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BACKGROUND Instent- restenosis is a major issue after all intravascular
interventional treatments applying stents. We retrospectively analyzed
data from our center with respect to instent-restenosis rates in patients
who had undergone carotid artery stenting (CAS) at our department.
METHODS We retrospectively analyzed 1137 consecutive patients
(pts) with a mean age of 71.7  38.6 years who had undergone 1150
interventional procedures of the carotid arteries at our institution
between December 1997 and January 2015,. Post-interventional
routine follow-up with an ultrasound examination was scheduled at
one as well as six months after the procedure and after that on a yearly
basis. Signiﬁcant instent-restenosis was deﬁned as a lumen narrowing
>50% within the stent as assessed by Doppler velocities of more than
200 cm/second. Patients were divided into two groups with respect to
the stents used. 462 stenoses (40.2%) were treated with balloon-
expandable stents (group 1), whereas the remaining 688 stenoses
(59.8%) were treated with self-expandable stents (group 2).
RESULTS Long term follow-up with a mean duration of 38 months
showed an instent-restenoses rate of 6.8% (78 pts) for the entire cohort. In
group 1, instent-restenoses occurred in 54 pts (11.7%), in group 2, in 24 pts
(3.5%; p<0.001 for between group difference). Initial post-dilatation was
performed in 81 pts (17.5%) in group 1 but in 564 pts (82.0%) in group 2
(p<0.001). We found post-dilatation to signiﬁcantly decrease the in
instent-restenosis rate in group 1 (post-dilatation vs. no post-dilatation:
p¼0.037), but not in group 2 (post-dilatation vs. no post-dilatation:
p¼0.860). In group 2, no differencewas found between patientswhowere
treated with tapered or non-tapered stents (p¼0.114), respectively.
CONCLUSIONS Instent-restenoses >50% after CAS occurred infre-
quently during long term follow-up (6.8%) in our cohort. This state-
ment held true especially for those patients who had been treated
with self-expandable stents (3.5%). In patients who had been treated
with balloon-expandable stents, post-dilatation reduced instent-
restenoses signiﬁcantly. The shape of self-expandable stents did not
inﬂuence the instent-restenosis rate.
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BACKGROUND Recently transradial (TR) approach became a safe and
effective alternative of percutaneous carotid intervention (CI). Wereport the learning curve over 5 years in two high-volume interven-
tional centers during the transition from transfemoral (TF) to trans-
radial approach.
METHODS Between 2010 and 2014, 1541 patients underwent CI in our
centers. Clinical characteristics, radiation doses, volume of contrast
material, screening and procedure times of consecutive patients were
recorded prospectively in a register and restrospectively analyzed.
RESULTS Transradial approach was applied in 323 patients, mean age
was 686 years, 66% of them was male. The ratio of TR has grown
from 3 to 7, 25, 43 and 48% of the CIs, during the years respectively.
While the duration of the procedure (22.5 vs. 26 min, p¼0.016), the
ﬂuoroscopy time (7.4 vs. 9.7 min, p<0.001) and the applied contrast
material (90 vs. 128 ml, p<0.001) has signiﬁcantly decreased. How-
ever, these parameters were independent of the type of the aortic
arch. Conversion to TF was needed in 8.9% and remained stable. No
difference was observed in the incidence of minor or major vascular
events and hospitalization days, over the years.
CONCLUSIONS There was an initial learning curve for ﬂuoroscopy
time, contrast material. The change from TF to TR approach is
achievable in 5 years in high-volume centers.
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BACKGROUND Ischemic stroke is a dreaded complication feared by
patients (pts) with atrial ﬁbrillation (AF). The CHADS2 & CHA2DS2-
VASc scores are the gold standard for stroke risk stratiﬁcation in AF
pts; larger scores indicate higher risk of developing stroke and guide
anticoagulation strategy. This study evaluates CHADS2 and CHA2DS2-
VASc Scores in patients at the time of presentation with stroke.
METHODS We queried the institutional stroke data base in collaboration
with the stroke service to identify all pts with AF who presented with an
acute stroke. 86 consecutive pts with AF who presented with an acute
stroke to an urban teaching hospital between 2011-2014 were analyzed.
RESULTS 46 pts (53.5%) were women and 40 pts (46.5%) were men,
with mean age 77.311.2 years; 50 pts had persistent AF, 30 pts had
paroxysmal AF, and 6 pts had new onset AF. Hypertension and
obstructive sleep apnea were present in 93% and 4.7%, respectively.
Only 2 pts (1.2 %) had a CHADS2 score >5; the score was 0-1 in 8 pts
(9.3%). CHA2DS2-VASc score was low-intermediate risk (3-5) in 72.1%
and only 16.3% pts had a score > 5. The graphs show that the largest
incidence of stroke occurred in pts with low to intermediate risk
scores, not high risk. Warfarin was the prescribed anticoagulant in 31
pts, while only 3, 2, and 1 pts respectively were taking rivaroxaban,
dabigatran, and apixaban. The INR at the time of stroke for pts on
warfarin was therapeutic in 6 pts, sub-therapeutic in 20 pts, and su-
per-therapeutic in 5 pts. Reasons for the absence of anticoagulation in
the other 49 pts included non-compliance, bleeding history, high fall
risk, perioperative condition, physician decision, and patient refusal.
